Feb 25, 2026In a significant advancement for pediatric healthcare delivery, Coral Care secured $13 million in Series A funding led by Haymaker Ventures. This investment aims to scale Coral Care's innovative in-home therapy services for children, improving access and outcomes for young patients suffering from developmental and physical challenges. The funding round attracted multiple strategic investors, underlining confidence in Coral Care's mission to transform pediatric care.
The Catalyst Brief
Feb 23, 2026Healthcare leaders highlight at a recent ViVE conference that sustaining rural hospitals is critical to preserving economic vitality as well as ensuring access to essential care for rural populations. The multifaceted rural healthcare crisis requires attention beyond medical concerns to economic policy and infrastructure.
The Catalyst Brief
Feb 22, 2026The recent acquisition positions Hims & Hers to broaden its footprint beyond traditional markets, signaling strategic moves to mitigate domestic regulatory pressures affecting GLP-1 therapies. This analysis explores the acquisition's implications on the company's growth trajectory and its broader market impact.
The Catalyst Brief
Feb 20, 2026As the healthcare system increasingly adjusts to novel CMS payment and care delivery standards, startups like Rainfall Health are positioned to support hospitals through these transitions. Their recent $15 million funding round, led by Two Bear Capital, underscores the critical intersection of technology, policy, and hospital operations.
The Catalyst Brief
Feb 20, 2026Frist Cressey Ventures recently secured $425 million in its fourth fund to back promising early-stage healthcare startups. The fund targets companies leveraging artificial intelligence to enhance healthcare delivery, reduce costs, and address challenges related to the aging population.
The Catalyst Brief
Feb 19, 2026This initiative marks a significant stride in connecting patients with holistic digital mental health, coaching, and therapy services offered by Calm and Lyra Health. The network aims to address growing behavioral health needs through accessible and innovative digital platforms.
The Catalyst Brief
Feb 18, 2026PitchBook's analysis reveals that $33.8 billion was invested in biopharma during 2025, predominantly directed to companies with advanced stage programs close to clinical implementation. Early-stage firms are facing significant hurdles in securing venture funding amid rising concerns over risk and regulatory uncertainty.
The Catalyst Brief
Feb 16, 2026Medicare Advantage, a key segment in the healthcare insurance landscape, has experienced dwindling membership growth as several leading insurers, including UnitedHealth, Humana, and Aetna, have been actively reducing their rolls. This development follows a series of changes affecting the program and could signal a major shift in the sector.
The Catalyst Brief
Feb 12, 2026This post explores the recent $210 million funding round for Talkiatry aiming to leverage AI for patient engagement, alongside Big Health's $24 million raise that underscores renewed investor optimism in digital therapeutics. Additionally, insights into the reassessment of the Apple Watch hypertension feature provide a backdrop for innovations in health technology.
The Catalyst Brief
Feb 10, 2026The healthcare startup Solace Health has become a unicorn, valued at over $1 billion after a significant funding round. Its unique approach eliminates the traditional burden on patients by proactively handling scheduling, insurance, and care coordination.
The Catalyst Brief
Feb 6, 2026The biotechnology sector has witnessed a notable resurgence in initial public offerings (IPOs) with Eikon Therapeutics leading the way by raising $381 million to fund clinical trials for cancer immunotherapy. This development may influence market dynamics and investor sentiment within the sector.
The Catalyst Brief
Feb 6, 2026In 2026, the digital health sector sees accelerated consolidation as companies strive to grow and innovate in a competitive landscape shaped by payer and investor pressures. Artificial intelligence emerges as a pivotal factor influencing deal-making and strategic integration within the industry.
The Catalyst Brief
